Winslow Brendan R.
SEC CIK 2105552 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RNA | Atrium Therapeutics, Inc. | CFO | 36.9K | — | — | 2 | 2026-04-20 | 2026-09-18 |
Most active insiders at RNA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Younis Husam | CSO | — | — |
| 2 | Hoyos Rocio Martin | Chief Strategy Off | — | — |
| 3 | Winslow Brendan R. | CFO | — | — |
| 4 | Kenney Stephanie | See Remarks | — | — |
| 5 | Gallagher Kathleen P. | See Remarks, Dir | — | — |
| 6 | Flanagan W. Michael | Dir | — | — |
| 7 | Hughes Steven George | Chief Medical Off | — | — |
| 8 | Boyce Sarah | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-22 16:17 | 2026-09-18 | RNA | Atrium Therapeutics, Inc. | Winslow Brendan R. | CFO | F - Tax | $8.95 | -6,742 | 36.9K | -15% | -$60.3K | |
| D | 2026-04-22 17:53 | 2026-04-20 | RNA | Atrium Therapeutics, Inc. | Winslow Brendan R. | CFO | A - Grant | $0.00 | +30.0K | 43.6K | +221% | $0 |
Purchase Sale Sale after option exercise All abbreviations